Dr. Szymczuk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave NW
Washington, DC 20010Phone+1 202-476-5000
Summary
- Vivian Szymczuk, MD is a specialist in pediatric endocrinology based in Washington, DC. She completed her pediatrics residency at the University of Illinois College of Medicine at Peoria in 2019, and her pediatric endocrinology fellowship at the NIH Clinical Center in 2023. She is currently a Research Clinician at the National Institutes of Health in the Metabolic Bone Disorders Unit. Her experience spans pediatric endocrinology, pediatrics, and research. She has authored several publications, including studies on denosumab treatment and endocrine surveillance, and has been involved in clinical trials on treatments for fibrous dysplasia. Dr. Szymczuk has previously completed research with the the Rubin Institute for Advanced orthopedics at Sinai Hospital of Baltimore and the Department of Cellular and Molecular Medicine in Ottawa Canada. Dr. Szymczuk holds a medical degree from the University of Medicine & Health Sciences St. Kitts and a BS in Human Physiology and Molecular Medicine from the University of Ottawa.
Education & Training
- National Institutes of Health Clinical Center/Eunice Kennedy Shriver NICHDFellowship, Pediatric Endocrinology, 2023
- NIH Clinical CenterPediatric Endocrinology, 2023
- University of Illinois College of Medicine at PeoriaResidency, Pediatrics, 2016 - 2019
- University of Medicine & Health Sciences St. KittsClass of 2015
- University of Ottawa BS, Human Physiology, Molecular medicine, Honors
Certifications & Licensure
- MD State Medical License 2020 - Present
- DC State Medical License 2020 - 2024
- IL State Medical License 2016 - 2023
- ME State Medical License 2019 - 2021
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome Start of enrollment: 1998 Dec 13
- Denosumab Treatment for Fibrous Dysplasia Start of enrollment: 2019 Jun 13
Publications & Presentations
PubMed
- Safety and Efficacy of Moderate-Dose Denosumab in Fibrous Dysplasia: Observational Results from a Phase 2 Clinical Trial.Vivian Szymczuk, Ibrahim I Elbashir, Ramzy Ahmed, Luis F de Castro, Kelly Milligan
The Journal of Clinical Endocrinology and Metabolism. 2024-12-13 - Is endocrine surveillance important in the care of Duchenne Muscular Dystrophy? Results from a national survey to patients and families on endocrine complications.Despoina Galetaki, Vivian Szymczuk, Melody Shi, Nadia Merchant
Eneurologicalsci. 2024-09-01 - 1 citationsPersistent Gynecomastia due to Short-term Low-dose Finasteride for Androgenetic Alopecia.Hal Steven Farkas, Youn Hee Jee, Vivian Szymczuk, Ellen Werber Leschek
JCEM Case Reports. 2024-05-01
Abstracts/Posters
- Childhood Diabetic Ketoacidosis (DKA) in New-Onset and Established Patients in Central Illinois: Contributing Factors and Risk StratificationVivian Szymczuk, MD, James Dunneback, MD, Yanzhi Wang, PhD, Valeria C Benavides, MD,MPH, Journal of the Endocrine Society, Volume 4, Issue Supplement_1, 5/3/2020
Professional Memberships
- Member
- Pediatric Endocrine SocietyMember
- Endocrine SocietyMember
- American Medical AssociationMember
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: